Emerging Psoriasis and Psoriatic Arthritis Therapies Expand Treatment Landscape
For dermatologists, the continued emergence of new targeted therapies requires careful patient selection and vigilance regarding long-term safety.
Related Articles
FDA Launches Agency-Wide AI Rollout by 2025
FDA accelerates AI integration by 2025, enhancing scientific reviews and modernizing regulatory processes for improved public health outcomes.
Building Trust Through Cultural Competency in Aesthetic Dermatology
Explore how cultural competency in aesthetic dermatology bridges trust gaps, ensuring inclusive care for patients of color and enhancing treatment outcomes.
Psychopharmacology Update
This in-person conference is a wonderful opportunity to share in valuable face-to-face engagement while also learning about the latest advancements in the field. Once again,…
Thin Skinned: Topical Steroid Safety and Legal Landmines – JDDonline – Journal of Drugs in Dermatology
Just put some salve on it” sounds so innocuous one could follow up with, “what could possibly go wrong?” Never ask that. Yes, our skin…
Survey Snapshot: Chronic Hand Eczema’s Clinical Burden, Treatment Gaps, and Patient Impact Revealed
We review survey data revealing diagnostic confusion, treatment gaps, and the emotional, social, and occupational toll of moderate to severe chronic hand eczema.
Isatuximab Monotherapy Shows Durability and Efficacy for Heavily Pretreated R/R Multiple Myeloma
Isatuximab as monotherapy for the treatment of patients with relapsed/refractory multiple myeloma demonstrated improved cancer outcomes and durable responses.
Treatment of Synovitis, Acne, Pustulosis, Hyperstosis, and Osteitis Syndrome With Abrocitinib
This case report describes a woman in her 50s who was initially diagnosed with palmoplantar pustulosis but was subsequently found to have synovitis, acne, pustulosis,…
Nail Care’s Hidden Health Costs
Explore the hidden health risks of nail products and the urgent need for safety reforms in the nail salon industry for workers and customers alike.
JDD Article on HA Fillers Gets a Beauty Spotlight—Here’s Why Dermatologists Should Take Note – JDDonline – Journal of Drugs in Dermatology
When a recent article of Allure recently explored the science behind “medical-grade” skincare and aesthetic procedures, they touched on a topic that’s central to many…
Potential Activity of Afatinib Among Patients With Advanced Solid Tumors With NGR1 Fusions
According to a case series of patients enrolled in the TAPUR trial, afatinib showed promising activity among patients with advanced solid tumors harboring neuregulin 1…